¼øõÇâ´ëÇб³ºÎõº´¿ø ¼øõÇâ ÀÇÇבּ¸ Çмú´ëȸ 2019 : 2019-11-03±³À°ÀÏÀÚ : 2019-11-03
±³À°Àå¼Ò : °æ±âµµ ºÎõ½Ã Á¶¸¶·ç·Î170 ¼øõÇâ´ëÇб³ºÎ¼ÓºÎõº´¿ø 5Ãþ Çâ¼³´ë°´ç
±³À°ÁÖÁ¦ :
¼øõÇâ ÀÇÇבּ¸ Çмú´ëȸ 2019ÁÖÃÖ±â°ü : ¼øõÇâ´ëÇб³ºÎõº´¿ø
´ã´çÀÚ : À̼ҿ¬
¿¬¶ôó : 032-621-6360
À̸ÞÀÏ :
soyun@schmc.ac.kr ±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, Á¤½Å°Ç°ÀÇÇаú, Á¤Çü¿Ü°ú, ½Å°æ¿Ü°ú, ÈäºÎ¿Ü°ú, ¼ºÇü¿Ü°ú, ¾È°ú, À̺ñÀÎÈÄ°ú, ÇǺΰú, ºñ´¢ÀÇÇаú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, ¸¶ÃëÅëÁõÀÇÇаú, ½Å°æ°ú, ÀçÈ°ÀÇÇаú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú, ÇÙÀÇÇаú, ÀÀ±ÞÀÇÇаúÀÇ»çÇÐ, ÇغÎÇÐ, ¹Ì»ý¹°ÇÐ, ÀÇ·áÄ¿¹Â´ÏÄÉÀ̼Ç, ÀÇÇб³À°, ÀÇ·á°æ¿µ
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª :
°æ±âµµ±³À°½Ã°£ : 5 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 10,000¿ø
ºñ°í »çÀüµî·Ï : ¹«·á ÇöÀåµî·Ï : 1¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-03 Çâ¼³´ë°´ç 09:30~09:50 Pharmabiotics based on microbiome; current status and future prospect ¼ÛÈ£¿¬(¼øõÇâ´ëÇб³ ¹Ì»ý¹°Çб³½Ç)
±³À°½Ã°£ 11-03 Çâ¼³´ë°´ç 09:50~10:10 New pathways for the treatment of type 2 diabetes ÀÌÁ¾¼ø(¼øõÇâÀÇ»ý¸í¿¬±¸¿ø)
±³À°½Ã°£ 11-03 Çâ¼³´ë°´ç 10:10~10:30 Novelty and future of 3D printed implants for spinal disease ÀÓ¼öºó(¼øõÇâ´ëºÎ¼ÓºÎõº´¿ø ½Å°æ¿Ü°ú)
Åä·Ð 11-03 Çâ¼³´ë°´ç 10:30~10:40 Q & A ()
ÈÞ½Ä 11-03 Çâ¼³´ë°´ç 10:40~11:00 Coffee Break ()
±³À°½Ã°£ 11-03 Çâ¼³´ë°´ç 11:00~11:30 ÀÇ»ç°úÇÐÀÚ ¾ç¼ºÀ» À§ÇÑ Á¦¾ð : Ä«À̽ºÆ® ÀÇ°úÇÐ ´ëÇпøÀÇ ¼³¸³°úÁ¤°ú ¼º°ø»ç·Ê À¯¿íÁØ(Ä«À̽ºÆ® ÀÇ°úÇдëÇпø)
±³À°½Ã°£ 11-03 Çâ¼³´ë°´ç 11:30~12:00 Precision lunch, for my personal genome and health record ±èÁÖÇÑ(¼¿ïÀÇ´ë Á¤º¸ÀÇÇÐ)
ÈÞ½Ä 11-03 Çâ¼³´ë°´ç 12:00~13:00 Lunch ()
±³À°½Ã°£ 11-03 Çâ¼³´ë°´ç 13:00~13:15 Clinical impact of circulating exosomal microRNA as a novel biomarker of liver fibrosis ÀåÀ翵(¼øõÇâ´ëºÎ¼Ó¼¿ïº´¿ø ¼Òȱ⳻°ú)
±³À°½Ã°£ 11-03 Çâ¼³´ë°´ç 13:15~13:30 New insight of IPF pathogenesis; necroptosis and IL-37 ¹Ú¼º¿ì(¼øõÇâ´ëºÎ¼ÓºÎõº´¿ø È£Èí±â¾Ë·¹¸£±â³»°ú)
±³À°½Ã°£ 11-03 Çâ¼³´ë°´ç 13:30~13:45 Role of trained immunity on the development of metabolic disease in high risk patients Àü¼º¿Ï(¼øõÇâ´ëºÎ¼Óõ¾Èº´¿ø ³»ºÐºñ´ë»ç³»°ú)
±³À°½Ã°£ 11-03 Çâ¼³´ë°´ç 13:45~14:00 Generalized phenotypical characteristics of emotional/cognitive sequela and its noveltherapeutic approaches following mild ischemic stroke ±è´ö¼ö(¼øõÇâ´ëÇб³ ÇغÎÇб³½Ç)
±³À°½Ã°£ 11-03 Çâ¼³´ë°´ç 14:00~14:15 Pathogenetic role of UBE2O in cancer and diabetes ¼Û¼öÁ¤(¼øõÇâÀÇ»ý¸í¿¬±¸¿ø)
Åä·Ð 11-03 Çâ¼³´ë°´ç 14:15~14:30 Q & A ()
ÈÞ½Ä 11-03 Çâ¼³´ë°´ç 14:30~14:50 Coffee Break ()
±³À°½Ã°£ 11-03 Çâ¼³´ë°´ç 14:50~15:10 Development of AI-based anesthetic complication prediction system ¿ìÁö¿µ(¼øõÇâ´ëÇб³ ºòµ¥ÀÌÅÍ°øÇаú)
±³À°½Ã°£ 11-03 Çâ¼³´ë°´ç 15:10~15:30 Engineering the biointerface using a 3D bioprinting technology from stem cells tofunctional biomaterials Ȳ¿ë¼º(¼øõÇâÀÇ»ý¸í¿¬±¸¿ø)
±³À°½Ã°£ 11-03 Çâ¼³´ë°´ç 15:30~15:50 Continuous synthesis of functional nanoparticles for drug delivery systems ÀÓÁ¾¹Î(¼øõÇâ´ëÇб³ ³ª³ëÈÇаøÇаú)
Åä·Ð 11-03 Çâ¼³´ë°´ç 15:50~16:00 Q & A ()
±³À°½Ã°£ 11-03 Çâ¼³´ë°´ç 16:00~16:20 Çâ¼³ À¶ÇÕ ÀÇÇבּ¸ ¼º°ú »ç·Ê ¹ßÇ¥ ¹é¹«ÁØ(¼øõÇâ´ëºÎ¼Óõ¾Èº´¿ø ¿¬±¸ºÎ)
±³À°½Ã°£ 11-03 Çâ¼³´ë°´ç 16:20~16:40 »êÇÐÇù·Â´Ü ¿¬±¸ Áö¿ø »ç¾÷ ¾È³» À±Çü¼±(¼øõÇâ´ëÇб³ »êÇÐÇù·Â´Ü)
±âŸ 11-03 Çâ¼³´ë°´ç 16:40~17:00 Closing Remark Ȳ°æÈ£(¼øõÇâ´ëÇб³ Áß¾ÓÀÇ·á¿ø)